Poly(histidine-arginine)6 modified chitosan nanoparticle for siRNA delivery in melanoma therapy

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-B-057-Tuesday
• By: SUN, Ping (Institute of Materia Medica, Department of Pharmaceutics, Beijing, China)
• Co-author(s): Ping Sun: Department of Pharmaceutics, Institute of Materia Medica, Beijing, China
  Zhonggao Gao: Department of Pharmaceutics, Institute of Materia Medica, Beijing, China
  
• Abstract:

  Backgrounds

       Chitosan(CS) received more attention as small interfering RNA(siRNA )delivery carrier because of its low toxicity and biodegradable, however, extensive application of chitosan in gene therapy was limited due to its low transfection efficiency.

  Aims

       To prepare siRNA delivery carrier with high transfection efficiency.
  

   

  Methods

      

  
  
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login